• Overarching Political Issues

Steady as she goes in the Spring Statement

Dr Martin Turner, BIA Policy and Projects Manager, takes a look at today's Spring Statement from Chancellor Phillip Hammond and its implications for the bioscience sector.

CEO Update: Monday 12 March

Today, the Business Secretary Greg Clark has announced that the government is investing over £300 million from its Industrial Strategy Challenge Fund (ISCF) to bring together the UK’s world-class research expertise with business investment to develop technologies and industries that can help the UK prepare for the challenge of an ageing society. £210 million will be invested in the ‘data to early diagnosis and precision medicine’ challenge which will see the UK lead the world in the development of innovative new diagnostic tools, medical products and treatments.

CEO Update Monday 5 March 2018

On Friday the Prime Minister announced that the UK will seek to explore with the EU, the terms on which the UK could remain part the European Medicines Agency, abide by the rules of the agency and make an appropriate financial contribution. It’s good to see the PM articulating  the practical dynamics of our industry of the future, when she said in her speech that ‘membership of the European Medicines Agency would mean investment in new innovative medicines continuing in the UK, and it would mean these medicines getting to patients faster as firms prioritise larger markets when they start the lengthy process of seeking authorisations.’        

UK life science backs May's plan to remain part of EMA

BIA welcomes the Prime Minister’s announcement today that the UK will seek to explore with the EU, the terms on which the UK could remain part the European Medicines Agency, abide by the rules of the agency and make an appropriate financial contribution.

Guest Blog: 'What the Sector Deal means for Life Sciences Skills' - By Dr Malcolm Skingle, SIP Chair

Malcolm Skingle, Science Industry Partnership (SIP) Chair, looks at the key elements recent Life Sciences Sector Deal and what we can expect to see as a result of it in the coming years.

CEO Update: Monday 26 February 2018

This week is set to be a big week for Brexit news as we expect to see key positioning statements from the UK government and the official Labour opposition with a key focus on the customs union. The Prime Minister is expected to speak towards the end of this week following a special Cabinet meeting on Thursday. The speech follows the "war Cabinet" meeting at her country residence Chequers that was held last week to work out a forthcoming Brexit negotiations strategy.

Guest blog: 'Doing the maths: why business needs to get on board' - By Dr Gillian Burgess

Dr. Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case for promoting greater uptake of maths to support individuals in undertaking the science jobs of today and tomorrow.

CEO Update: Monday 19 February

This week we are gearing up for our 2018 Committee Summit taking place on Thursday, kindly hosted by Simmons and Simmons. The event will see around 180 expert BIA members gather for all eight of the BIA’s advisory committees coming together. In addition, this year we are running a plenary session on the implications of the Nagoya protocol for our sector.

CEO Update: Monday 12 February

Thank you to all our members who joined our Brexit lead event last week. It was great to be able to share perspectives on what is a fast moving key issue. I was pleased that members confirmed that we should stay our course on the Brexit priorities agreed last year, which we will keep stressing to the UK government, and with our European partner associations to the EU-27.

Launch of the China Biotech Special Interest Group

Last week saw the launch event for the China Biotech Special Interest Group. We had an excellent turn out at the China-Britain Business Council offices in Victoria, with people coming to hear BIA members talk about their different experiences in China.